-- China's drug regulator approved Apeloa Pharmaceutical's (SHE:000739) registration for its fluvastatin sodium extended-release tablets, according to a Thursday filing with the Shenzhen bourse.
Fluvastatin sodium is indicated for cholesterol lowering, the filing said.